FRITZ ROC

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease SYRACUSE, NY NPI 1790784411

General Payments — all program years on this page

$4,551.62

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 303
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $330.76 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $330.7616

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,353.7794
2019 $1,106.4382
2020 $572.8039
2021 $391.5223
2022 $579.9438
2023 $216.4011
2024 $330.7616

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078120140 Janssen Pharmaceuticals, Inc $20.89 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087247377 Novartis Pharmaceuticals Corporation $25.88 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087247379 Novartis Pharmaceuticals Corporation $22.03 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087247387 Novartis Pharmaceuticals Corporation $28.56 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087247393 Novartis Pharmaceuticals Corporation $24.52 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097073512 Novo Nordisk Inc $13.64 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101351232 E.R. Squibb & Sons, L.L.C. $16.44 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105796978 AstraZeneca Pharmaceuticals LP $14.59 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111690078 Amgen Inc. $22.88 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111690080 Amgen Inc. $18.40 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118157125 Boehringer Ingelheim Pharmaceuticals, Inc. $20.08 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119488078 Medtronic, Inc. $24.42 02/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130893089 PFIZER INC. $14.04 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141807007 Merck Sharp & Dohme LLC $14.28 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141807009 Merck Sharp & Dohme LLC $22.64 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141947105 Merck Sharp & Dohme LLC $27.47 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.